Amundi Discloses 5.04% Passive Stake in Sanofi via Schedule 13G/A

On April 10, 2026, Amundi and its subsidiary Amundi Asset Management filed a Schedule 13G/A regarding their holdings in Sanofi (SNY). The filing reveals that the French asset management group now beneficially owns 61,506,935 shares of Sanofi's common stock and American Depositary Receipts, representing a 5.04% ownership stake. This position is held across various subsidiaries, including Amundi Ireland Limited and Amundi Japan Ltd. The filing notes a specific arrangement regarding 27,407,379 of these shares, which are held through an employee shareholding vehicle (FCPE) for Sanofi group employees. Amundi does not exercise voting rights for these specific shares; instead, voting power is managed by the FCPE's supervisory board, which is primarily composed of employee representatives. Consequently, Amundi reports shared voting power over 30,913,670 shares while maintaining shared dispositive power over the full 61,506,935 shares. The securities were acquired in the ordinary course of business and not for the purpose of influencing control over the issuer.